- Home
- ADV vs AUTL Comparison
ADV vs AUTL Comparison
Compare ADV & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADV
- AUTL
- Stock Information
- Founded
- ADV 1987
- AUTL 2014
- Country
- ADV United States
- AUTL United Kingdom
- Employees
- ADV N/A
- AUTL N/A
- Industry
- ADV Business Services
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ADV Consumer Discretionary
- AUTL Health Care
- Exchange
- ADV Nasdaq
- AUTL Nasdaq
- Market Cap
- ADV 977.6M
- AUTL 1.1B
- IPO Year
- ADV N/A
- AUTL 2018
- Fundamental
- Price
- ADV $3.44
- AUTL $2.84
- Analyst Decision
- ADV Strong Buy
- AUTL Strong Buy
- Analyst Count
- ADV 1
- AUTL 3
- Target Price
- ADV N/A
- AUTL $10.20
- AVG Volume (30 Days)
- ADV 537.8K
- AUTL 2.6M
- Earning Date
- ADV 11-07-2024
- AUTL 11-12-2024
- Dividend Yield
- ADV N/A
- AUTL N/A
- EPS Growth
- ADV N/A
- AUTL N/A
- EPS
- ADV N/A
- AUTL N/A
- Revenue
- ADV $3,990,708,000.00
- AUTL $10,091,000.00
- Revenue This Year
- ADV N/A
- AUTL $816.67
- Revenue Next Year
- ADV $2.10
- AUTL $374.47
- P/E Ratio
- ADV N/A
- AUTL N/A
- Revenue Growth
- ADV N/A
- AUTL 82.71
- 52 Week Low
- ADV $2.60
- AUTL $2.69
- 52 Week High
- ADV $4.95
- AUTL $7.45
- Technical
- Relative Strength Index (RSI)
- ADV 55.79
- AUTL 32.80
- Support Level
- ADV $3.05
- AUTL $3.24
- Resistance Level
- ADV $3.59
- AUTL $3.25
- Average True Range (ATR)
- ADV 0.28
- AUTL 0.33
- MACD
- ADV 0.02
- AUTL -0.08
- Stochastic Oscillator
- ADV 46.43
- AUTL 10.49
About ADV Advantage Solutions Inc.
Advantage Solutions Inc is the provider of outsourced sales and marketing solutions to consumer goods companies and retailers. It has a technology-enabled platform of sales and marketing services like headquarter sales, retail merchandising, in-store sampling, digital commerce, and shopper marketing. For brands and retailers of all sizes, the firm helps to get the right products on the shelf and into the hands of consumers. The company helps its clients to sell more while spending less. Advantage has offices throughout North America and strategic investments in select markets throughout Africa, Asia, Australia, and Europe through which it services the global needs of multinational, regional, and local manufacturers. Its services are provided across two segments sales and marketing.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.